Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,432,275
  • Shares Outstanding, K 309,844
  • Annual Sales, $ 2,394 M
  • Annual Income, $ -83,990 K
  • EBIT $ 219 M
  • EBITDA $ 456 M
  • 60-Month Beta 1.12
  • Price/Sales 1.01
  • Price/Cash Flow 5.77
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 92.31% ( +2.31%)
  • Historical Volatility 34.99%
  • IV Percentile 78%
  • IV Rank 43.95%
  • IV High 196.37% on 06/21/24
  • IV Low 10.73% on 10/11/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 71
  • Volume Avg (30-Day) 259
  • Put/Call OI Ratio 0.36
  • Today's Open Interest 5,614
  • Open Int (30-Day) 7,938

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.13
  • Number of Estimates 2
  • High Estimate 0.13
  • Low Estimate 0.12
  • Prior Year 0.12
  • Growth Rate Est. (year over year) +8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.57 +3.70%
on 12/20/24
8.90 -11.80%
on 12/05/24
-0.54 (-6.44%)
since 11/22/24
3-Month
7.52 +4.39%
on 11/08/24
9.48 -17.15%
on 11/12/24
-0.59 (-6.99%)
since 09/24/24
52-Week
5.01 +56.69%
on 03/01/24
9.48 -17.15%
on 11/12/24
+2.09 (+36.28%)
since 12/22/23

Most Recent Stories

More News
Amneal: Q3 Earnings Snapshot

Amneal: Q3 Earnings Snapshot

AMRX : 7.85 (+0.77%)
How to Find Great Cheap Stocks Under $10 to Buy in October

The S&P 500 jumped to fresh highs on Monday and the Nasdaq’s climb put it on the cusp of its July peaks. The strong start to the week came after JPMorgan and other Wall Street giants kicked off earnings...

AMRX : 7.85 (+0.77%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
LLY : 795.67 (-0.08%)
NVS : 98.35 (-0.10%)
TEVA : 22.42 (+0.95%)
AMRX : 7.85 (+0.77%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
LLY : 795.67 (-0.08%)
NVS : 98.35 (-0.10%)
TEVA : 22.42 (+0.95%)
AMRX : 7.85 (+0.77%)
Amneal: Q2 Earnings Snapshot

Amneal: Q2 Earnings Snapshot

AMRX : 7.85 (+0.77%)
Amneal: Q1 Earnings Snapshot

Amneal: Q1 Earnings Snapshot

AMRX : 7.85 (+0.77%)
Amneal: Q4 Earnings Snapshot

Amneal: Q4 Earnings Snapshot

AMRX : 7.85 (+0.77%)
Amneal: Q3 Earnings Snapshot

Amneal: Q3 Earnings Snapshot

AMRX : 7.85 (+0.77%)
Amneal: Q2 Earnings Snapshot

Amneal: Q2 Earnings Snapshot

AMRX : 7.85 (+0.77%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amneal Pharmaceuticals, Inc. - AMRX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NYSE: AMRX). Such...

AMRX : 7.85 (+0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 8.04
2nd Resistance Point 7.94
1st Resistance Point 7.90
Last Price 7.85
1st Support Level 7.76
2nd Support Level 7.66
3rd Support Level 7.62

See More

52-Week High 9.48
Last Price 7.85
Fibonacci 61.8% 7.77
Fibonacci 50% 7.24
Fibonacci 38.2% 6.72
52-Week Low 5.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar